LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma. | |
Ding Chenguang; Han Feng; Xiang Heli; Xia Xinxin; Wang Yuxiang; Dou Meng; Zheng Jin; Li Yang; Xue Wujun; Ding Xiaoming | |
刊名 | Journal of cellular biochemistry |
2018 | |
卷号 | 119页码:10406-10414 |
关键词 | renal carcinoma colorectal neoplasia differentially expressed (CRNDE) metastasis biomarker |
ISSN号 | 1097-4644 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2917917 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Ding Chenguang,Han Feng,Xiang Heli,et al. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.[J]. Journal of cellular biochemistry,2018,119:10406-10414. |
APA | Ding Chenguang.,Han Feng.,Xiang Heli.,Xia Xinxin.,Wang Yuxiang.,...&Tian Puxun.(2018).LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma..Journal of cellular biochemistry,119,10406-10414. |
MLA | Ding Chenguang,et al."LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.".Journal of cellular biochemistry 119(2018):10406-10414. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论